Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

被引:46
|
作者
Dong, Wenjie
Chen, Xiaobing [2 ]
Xie, Jing [3 ]
Sun, Pinghu
Wu, Yunlin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China
[2] Henan Tumor Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Pathol, Rui Jin Hosp, Shanghai 200025, Peoples R China
关键词
gastric cancer; methylation; HAI-2/SPINT2; HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; RENAL-CELL CARCINOMA; HUMAN BREAST-CANCER; C-MET; OVARIAN-CANCER; PROTEASE INHIBITOR; BIKUNIN HAI-2/PB; MOUSE MODEL; EXPRESSION;
D O I
10.1002/ijc.25161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.
引用
收藏
页码:1526 / 1534
页数:9
相关论文
共 50 条
  • [41] RAI2 acts as a tumor suppressor with functional significance in gastric cancer
    Lou, Xiaoli
    Deng, Wei
    Shuai, Lixiong
    Chen, Yijing
    Xu, Mengmeng
    Xu, Jingze
    Zhang, Yongsheng
    Wu, Yongyou
    Cao, Zhifei
    AGING-US, 2023, 15 (21): : 11831 - 11844
  • [42] Functional epigenomics identifies hepatocyte growth factor activator inhibitor type 2/SPINT2 as a frequently inactivated tumour suppressor in papillary and clear cell renal cell carcinoma
    Morris, M
    Gentle, D
    Abdulrahman, M
    Maina, EN
    Gupta, K
    Banks, RE
    Wiesener, MS
    Kishida, T
    Masahiro, Y
    Teh, B
    Latif, F
    Maher, ER
    JOURNAL OF MEDICAL GENETICS, 2005, 42 : S104 - S104
  • [43] SETD2: an epigenetic modifier with tumor suppressor functionality
    Li, Jun
    Duns, Gerben
    Westers, Helga
    Sijmons, Rolf
    van den Berg, Anke
    Kok, Klaas
    ONCOTARGET, 2016, 7 (31) : 50719 - 50734
  • [44] Mechanism for mutational inactivation of the tumor suppressor Smad2
    Prunier, C
    Ferrand, N
    Frottier, B
    Pessah, M
    Atfi, A
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (10) : 3302 - 3313
  • [45] Reversible inactivation of the tumor suppressor PTEN by H2O2
    Lee, SR
    Yang, KS
    Kwon, J
    Lee, C
    Jeong, W
    Rhee, SG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) : 20336 - 20342
  • [46] SETD2, an epigenetic tumor suppressor: a focused review on GI tumor
    Hu, Ming
    Hu, Mu
    Zhang, Qin
    Lai, Jin-ping
    Liu, Xiu-li
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2020, 25 : 781 - 797
  • [47] Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity
    Chiu, Yi-Lin
    Wu, Yi-Ying
    Barndt, Robert B.
    Lin, Yu-Wen
    Sytwo, Hou-Ping
    Cheng, Amy
    Yang, Kacy
    Chan, Khee-Siang
    Wang, Jehng-Kang
    Johnson, Michael D.
    Lin, Chen-Yong
    GENES & DISEASES, 2022, 9 (04) : 1049 - 1061
  • [48] Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer
    Kikuchi, Ryoko
    Tsuda, Hitoshi
    Kozaki, Ken-ichi
    Kanai, Yae
    Kasamatsu, Takahiro
    Sengoku, Kazuo
    Hirohashi, Setsuo
    Inazawa, Johji
    Imoto, Issei
    CANCER RESEARCH, 2009, 69
  • [49] Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer
    Kikuchi, Ryoko
    Tsuda, Hitoshi
    Kozaki, Ken-ichi
    Kanai, Yae
    Kasamatsu, Takahiro
    Sengoku, Kazuo
    Hirohashi, Setsuo
    Inazawa, Johji
    Imoto, Issei
    CANCER RESEARCH, 2008, 68 (13) : 5067 - 5075
  • [50] Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells
    Chang, Hsiang-Hua D.
    Xu, Yuan
    Lai, Hongyu
    Yang, Xiaoyu
    Tseng, Chun-Che
    Lai, Ying-Jung J.
    Pan, Yu
    Zhou, Emily
    Johnson, Michael D.
    Wang, Jehng-Kang
    Lin, Chen-Yong
    PLOS ONE, 2015, 10 (03):